Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2019-11-19 | New | $6,000,000 | $6,000,000 | Debt Only | 06b | SEC link |
| 2018-07-18 | New | $15,508,713 | $15,508,713 | Equity Only | 06b | SEC link |
| 2017-04-20 | Amended | $18,410,010 | $6,381,434 | Equity Only | 06b | SEC link |
| 2015-12-01 | New | $12,028,576 | $12,028,576 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| James Bennethum | Director |
| Cory S. Freedland | Director |
| Cory Freedman | Director |
| Douglas Gessl | Executive |
| Doug Gessl | Executive |
| David Hirsch | Director |
| David Hirsch, M.D. | Director |
| Aidan King | Director |
| Aidan King, Mba, Cfa | Director |
| Jill Becker Mast | Director |
| Scott Morenstein | Director |
| Stephen Tullman | Director |
| James C. Walker | Director, Executive |